EP4380691 - METHODS FOR THE TREATMENT OF CANCER [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 10.05.2024 Database last updated on 09.09.2024 | |
Former | The international publication has been made Status updated on 10.02.2023 | ||
Former | unknown Status updated on 15.08.2022 | Most recent event Tooltip | 28.08.2024 | New entry: Renewal fee paid | Applicant(s) | For all designated states Institut Régional du Cancer de Montpellier (ICM) 208 Rue des Apothicaires Parc Euromédecine 34298 Montpellier Cedex 5 / FR | For all designated states INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE - INSERM 101, rue de Tolbiac 75013 Paris / FR | For all designated states UNIVERSITE DE MONTPELLIER 163, rue Auguste Broussonnet 34090 Montpellier / FR | [2024/24] | Inventor(s) | 01 /
LINARES, Laetitia 34160 St Jean de Cornies / FR | 02 /
FIRMIN, Nelly 34160 SAINT GENIÈS DES MOURGUES / FR | 03 /
MANTEAUX, Gabrielle 26300 BÉSAYES / FR | [2024/24] | Representative(s) | Cabinet Nony 11 rue Saint-Georges 75009 Paris / FR | [2024/24] | Application number, filing date | 22750725.8 | 05.08.2022 | [2024/24] | WO2022EP72123 | Priority number, date | EP20210306099 | 06.08.2021 Original published format: EP 21306099 | [2024/24] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2023012343 | Date: | 09.02.2023 | Language: | EN | [2023/06] | Type: | A1 Application with search report | No.: | EP4380691 | Date: | 12.06.2024 | Language: | EN | The application published by WIPO in one of the EPO official languages on 09.02.2023 takes the place of the publication of the European patent application. | [2024/24] | Search report(s) | International search report - published on: | EP | 09.02.2023 | Classification | IPC: | A61P35/00, C07K16/24, C07K16/28, A61K39/395, G01N33/53, G01N33/574 | [2024/24] | CPC: |
C07K16/248 (EP);
A61P35/00 (EP);
C07K16/2803 (EP);
C07K16/2866 (EP);
G01N33/574 (EP);
G01N33/57496 (EP);
G01N33/6869 (EP);
A61K2039/505 (EP);
A61K2039/55 (EP);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2024/24] | Extension states | BA | Not yet paid | ME | Not yet paid | Validation states | KH | Not yet paid | MA | Not yet paid | MD | Not yet paid | TN | Not yet paid | Title | German: | VERFAHREN ZUR BEHANDLUNG VON KREBS | [2024/24] | English: | METHODS FOR THE TREATMENT OF CANCER | [2024/24] | French: | PROCÉDÉS DE TRAITEMENT DU CANCER | [2024/24] | Entry into regional phase | 04.03.2024 | National basic fee paid | 04.03.2024 | Designation fee(s) paid | 04.03.2024 | Examination fee paid | Examination procedure | 04.03.2024 | Amendment by applicant (claims and/or description) | 04.03.2024 | Examination requested [2024/24] | 04.03.2024 | Date on which the examining division has become responsible | Fees paid | Renewal fee | 27.08.2024 | Renewal fee patent year 03 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [Y]DE102004033905 (NEUMANN KURT [DE]); | [XD]WO2019106126 (INST NAT SANTE RECH MED [FR], et al); | [A]WO2021130682 (OTSUKA PHARMA CO LTD [JP]); | by applicant | US541 | US5874 | EP0125023 | WO9109967 | EP0519596 | US5225539 | EP0592106 | WO9602576 | US5530101 | US5545807 | US5545806 | US5565332 | US5569825 | US5585089 | US5625126 | US5633425 | US5661016 | US5750373 | US5800988 | WO9932619 | US5981732 | US6015695 | US6046321 | US6107091 | WO0136646 | WO0168836 | US6365354 | US6410323 | US6506559 | US6566135 | US6566131 | US6573099 | US6765087 | WO2004078941 | US6838254 | WO2006074108 | WO2009076321 | WO2009098450 | US8329723 | WO2019106126 | US10759862 |